- Home
- ACHV vs AEYE Comparison
ACHV vs AEYE Comparison
Compare ACHV & AEYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACHV | AEYE |
|---|---|---|
| Founded | N/A | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 167.6M | 170.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ACHV | AEYE |
|---|---|---|
| Price | $4.65 | $13.06 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $15.50 | ★ $22.00 |
| AVG Volume (30 Days) | ★ 653.5K | 84.1K |
| Earning Date | 11-06-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $39,540,000.00 |
| Revenue This Year | N/A | $16.79 |
| Revenue Next Year | N/A | $11.30 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 18.57 |
| 52 Week Low | $1.84 | $8.91 |
| 52 Week High | $5.78 | $23.12 |
Technical Indicators
Market Signals| Indicator | ACHV | AEYE |
|---|---|---|
| Relative Strength Index (RSI) | 52.84 | 55.29 |
| Support Level | $4.45 | $11.95 |
| Resistance Level | $5.19 | $12.59 |
| Average True Range (ATR) | 0.32 | 0.63 |
| MACD | 0.01 | 0.18 |
| Stochastic Oscillator | 58.97 | 86.38 |
Price Performance
Historical ComparisonAbout ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
About AEYE AudioEye Inc.
AudioEye Inc is a software solution provider delivering immediate ADA and WCAG accessibility compliance at scale. Through patented technology, subject matter expertise and proprietary processes, it is eradicating all barriers to digital accessibility, helping creators get accessible and supporting them with ongoing advisory and automated upkeep. Trusted by the ADP, Tommy Hilfiger, A360 Media, Samsung, Landry's and others. It helps everyone identify and resolve issues of accessibility and enhance user experiences, automating digital accessibility for the widest audiences.